Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.

Phase 1/2 Completed 24 enrolled Tigenix S.A.U.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to asses the safety and efficacy of adipose-derived adult stem cells from healthy donnors for treatment of complex perianal fistulas in Crohn's disease.

Timeline

Start: 2009-06
Primary completion: 2010-09
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Darvadstrocel	Cell therapy	20 cells	Other
Subject	Darvadstrocel	Cell therapy	40 cells	Other

Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.

Summary

Timeline

Drugs

Indications